RT Journal Article
SR Electronic
T1 SARS-COV-2 INFECTION IN PRIMARY CARE: A SINGLE-CENTERED, RETROSPECTIVE, OBSERVATIONAL STUDY
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.30.21267074
DO 10.1101/2021.11.30.21267074
A1 de Yébenes, Pilar Galicia García
A1 Gutiérrez Cuevas, Juan José
A1 Chen Chen, Fang Fang
A1 Larrégola, Laura Santos
A1 Briega, Alberto Manzanares
A1 Rufo, Manuel Linares
YR 2021
UL http://medrxiv.org/content/early/2021/12/02/2021.11.30.21267074.abstract
AB Purpose to describe the clinical characteristics of patients with confirmed SARS-CoV-2 infection in primary care and to analyze the predictive role of different risk factors on prognosis, especially living conditions.Methods Retrospective longitudinal observational retrospective study by reviewing medical records from a primary care center since March 1 to April 30, 2020. Case definition of confirmed SARS-CoV-2 infection, sociodemographic data, clinical characteristics, comorbidity and living conditions were collected. The statistical analysis consisted in description of the sample, comparison of prognosis groups and analysis of prognostic factors.Results A sample of 70 patients with confirmed SARS-CoV-2 infection was obtained, with comorbidity mainly related to arterial hypertension, overweight/obesity, hypercholesterolemia, diabetes and chronic pulmonary pathology. Pneumonia was present in 66%. Exitus occurred in 14% of the sample. Factors associated with mortality were advanced age (84 vs 55; p<0.0001), arterial hypertension (78% vs 41%; p=0.040), asthma-COPD (56% vs 13%; p=0.008) and atrial fibrillation (56% vs 5%; p=0.001).Conclusions The study reflects the clinical practice of a primary care center. This kind of studies are essential to strengthen and reorganize the Health System and to try to anticipate the medium- to long-term consequences of COVID-19 on global health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local Clinical Research Ethics Committee (Comision local de Investigacion Sureste).INFORME DE LA COMISION LOCAL DE INVESTIGACION SURESTE. CODIGO de proyecto: 6 / 21I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors SARS-CoV-2severe acute respiratory syndrome coronavirus 2COVID-19severe acute respiratory syndrome coronavirus 2PCPrimary carePCCPrimary care centerCOPDchronic obstructive pulmonary diseaseNSAIDsNonsteroidal anti-inflammatory drugsACE inhibitorsAngiotensin-converting enzyme inhibitorsPCRpolymerase chain reaction